Virologic and Exploratory Immunologic Characterization of Relapsing Human Cytomegalovirus (HCMV) DNAemia in Solid Organ Transplant Recipients: A Prospective Observational Cohort Study.

Golnaz Amidpour, Poramed Winichakoon, Ilona Bahinskaya, Sara Marocco, Marcelo Cypel, Deepali Kumar, Atul Humar, Victor H Ferreira

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Golnaz AmidpourAjmera Transplant Centre, University Health Network, Toronto, ON, Canada.

Poramed WinichakoonAjmera Transplant Centre, University Health Network, Toronto, ON, Canada.ORCID https://orcid.org/0000-0003-2225-3706

Ilona BahinskayaAjmera Transplant Centre, University Health Network, Toronto, ON, Canada.ORCID https://orcid.org/0009-0004-4273-2207

Sara MaroccoAjmera Transplant Centre, University Health Network, Toronto, ON, Canada.

Marcelo CypelAjmera Transplant Centre, University Health Network, Toronto, ON, Canada.ORCID https://orcid.org/0000-0001-5652-1938

Deepali KumarAjmera Transplant Centre, University Health Network, Toronto, ON, Canada.

Atul HumarAjmera Transplant Centre, University Health Network, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-1751-7159

Victor H FerreiraAjmera Transplant Centre, University Health Network, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-1472-9711

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relapsing cytomegalovirus DNAemia remains a challenge after organ transplantation. We evaluated longitudinal viral loads and T-cell responses in 62 recipients, of whom 15 relapsed. Week 2 viral loads, but not viral decay slopes or HCMV-specific T-cell responses differed by relapse status, supporting further evaluation of early viral burden.

Indexed as

DNAemiaHCMVhuman cytomegalovirusorgan transplantationrelapseT cellsviral loads

Identifiers

PMID42872080

DOI10.1093/ofid/ofag625

PMCPMC13660685

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.